These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China. Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692 [TBL] [Abstract][Full Text] [Related]
8. Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017. Huband MD; Pfaller MA; Shortridge D; Flamm RK J Glob Antimicrob Resist; 2019 Dec; 19():56-63. PubMed ID: 30825698 [TBL] [Abstract][Full Text] [Related]
9. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010]. Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of common bacterial pathogens causing respiratory tract infections in Canada to lefamulin, a new pleuromutilin. Taylor RM; Karlowsky JA; Baxter MR; Adam HJ; Walkty A; Lagacé-Wiens P; Zhanel GG J Assoc Med Microbiol Infect Dis Can; 2021 Jun; 6(2):149-162. PubMed ID: 36341032 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of the pleuromutilin antibiotic BC-3781 against bacterial pathogens isolated in the SENTRY antimicrobial surveillance program in 2010. Paukner S; Sader HS; Ivezic-Schoenfeld Z; Jones RN Antimicrob Agents Chemother; 2013 Sep; 57(9):4489-95. PubMed ID: 23836172 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010). Sader HS; Flamm RK; Jones RN Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208 [TBL] [Abstract][Full Text] [Related]
14. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States. Pfaller MA; Farrell DJ; Sader HS; Jones RN Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951 [TBL] [Abstract][Full Text] [Related]
15. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents. Peric M; Browne FA; Jacobs MR; Appelbaum PC Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118 [TBL] [Abstract][Full Text] [Related]
16. Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018. Pfaller MA; Huband MD; Shortridge D; Flamm RK Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071045 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program. Zhang Y; Zhang F; Wang H; Zhao C; Wang Z; Cao B; Du Y; Feng X; Hu Y; Hu B; Ji P; Liu Z; Liu Y; Liao W; Lu J; Sun H; Wang Z; Xu X; Xu X; Yang Q; Yu Y; Zhang R; Zhuo C J Glob Antimicrob Resist; 2016 Jun; 5():36-41. PubMed ID: 27436464 [TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci. Wootton M; Bowker KE; Janowska A; Holt HA; MacGowan AP J Antimicrob Chemother; 1999 Oct; 44(4):445-53. PubMed ID: 10588304 [TBL] [Abstract][Full Text] [Related]
19. Results from the Solithromycin International Surveillance Program (2014). Farrell DJ; Flamm RK; Sader HS; Jones RN Antimicrob Agents Chemother; 2016 Jun; 60(6):3662-8. PubMed ID: 27044551 [TBL] [Abstract][Full Text] [Related]
20. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN; J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]